Floatz logo

Sra-333

Anxiety Disorder

Hannover Medical SchoolPhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Anxiety Disorder cohort.

Asset / SponsorPhaseRating
Risperdal
Tianjin Medical University General Hospital
Phase 4BBB
FLUOXETINE
Hannover Medical School
Phase 4BBB
Amitryptaline
University of Ghana Medical School
Phase 4BB
LAMOTRIGINE
Hannover Medical School
Phase 3BB
Alprazolam
Hannover Medical School
Phase 3BB

View all 9 →

Same molecule, other indications

Sra-333 is also rated in:

Dementia With Lewy Bodies (DLB)Dormant
BBB
Indicative ·
76 / 100
View asset →
DementiaDormant
BBB
Indicative ·
74 / 100
View asset →
Alzheimer's DiseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →